Cerebral Complication of Antifibrinolytic Therapy in the Treatment of Ruptured Intracranial Aneurysm
Authors:
- Akira YamauraAYAkira Yamaura
- Takao NakamuraTNTakao Nakamura
- Hiroyasu MakinoHMHiroyasu Makino
- Yashiro HagiharaYHYashiro Hagihara
- 1 January 1980
- journal article
- research article
- Published by S. Karger AG in European Neurology
- Vol. 19 (2) , 77-84
Abstract
Among the reported complications of the antifibrinolytic therapy in the treatment of ruptured intracranial aneurysms, nausea and vomiting, cerebral arteriopathy and secondary hydrocephalus would be a matter of concern in its possible CNS involvement. However, little is known about the possibility of direct cerebral effect in synthetic antifibrinolytics. A simply designed animal experiment disclosed remarkable effects on electroencephalography, blood flow of the cerebral cortex and intracranial pressure. Such antifibrinolytics should not be given intrathecally in any situation even if the accumulation of the agents in cerebrospinal fluid is essential to prevent recurrent hemorrhage.Keywords
This publication has 3 references indexed in Scilit:
- ECHO-ENCEPHALOGRAPHIC STUDY of VENTRICULAR DILATATION AFTER SUBARACHNOID HEMORRHAGE, WITH SPECIAL REFERENCE to the EFFECT of ANTIFIBRINOLYTIC TREATMENTActa Neurologica Scandinavica, 1976
- Regional Blood Flow in the Cerebral Cortex, Measured Simultaneously by Heat and Inert Gas ClearanceActa Physiologica Scandinavica, 1966
- Experimental and Clinical Studies on AMCA, the Antifibrinolytically Active Isomer of p‐Aminomethyl Cyclohexane Carboxylic AcidScandinavian Journal of Haematology, 1965